VIATRIS INC. Acquisitions, Net of Cash Acquired
VIATRIS INC. (VTRS) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-02-26
- VIATRIS INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-31 was $0.00.
- VIATRIS INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-30 was $0.00.
- VIATRIS INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-06-30 was $0.00.
- VIATRIS INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- VIATRIS INC. payments to acquire businesses, net of cash acquired for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- VIATRIS INC. payments to acquire businesses, net of cash acquired for fiscal 2024 was $350.00M, a 47.58% decline from fiscal 2023.
- VIATRIS INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $667.70M.
- VIATRIS INC. payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $350.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $350.00M 10-Q · filed 2025-11-06 | $350.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $350.00M 10-Q · filed 2025-08-07 | $350.00M derived: sum of 3 quarters · filed 2026-02-26 | $350.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $350.00M 10-Q · filed 2025-05-08 | $350.00M derived: sum of 2 quarters · filed 2026-02-26 | $350.00M derived: sum of 3 quarters · filed 2026-02-26 | $350.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $667.70M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $667.70M 10-Q · filed 2024-11-07 | $667.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $667.70M 10-Q · filed 2024-08-08 | $667.70M derived: sum of 3 quarters · filed 2025-02-27 | $667.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $667.70M 10-Q · filed 2024-05-09 | $667.70M derived: sum of 2 quarters · filed 2025-02-27 | $667.70M derived: sum of 3 quarters · filed 2025-02-27 | $667.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | -$277.00M 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | -$277.00M 10-Q · filed 2022-11-07 | -$692.80M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$277.00M 10-Q · filed 2022-08-08 | -$692.80M derived: sum of 3 quarters · filed 2023-02-27 | -$692.80M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$277.00M 10-Q · filed 2022-05-09 | -$692.80M derived: sum of 2 quarters · filed 2023-02-27 | -$692.80M derived: sum of 3 quarters · filed 2023-02-27 | -$692.80M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$415.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$415.80M derived: sum of 2 quarters · filed 2023-02-27 | -$415.80M derived: sum of 3 quarters · filed 2023-02-27 | -$415.80M 10-K · filed 2023-02-27 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $148.70M 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $65.90M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |